MAOI处方:将误解与现实分离

The Prescriber Pub Date : 2023-07-01 DOI:10.1002/psb.2077

Aisling Molloy

{"title":"MAOI处方:将误解与现实分离","authors":"Aisling Molloy","doi":"10.1002/psb.2077","DOIUrl":null,"url":null,"abstract":"Monoamine oxidase inhibitors (MAOIs) are generally only initiated by specialists because of safety concerns, making GPs more wary of these medicines. This article discusses the important side‐effects and interactions of MAOIs and how these can be minimised, and explains why MAOI prescribing may be safer than we are led to believe.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MAOI prescribing: separating misconceptions from reality\",\"authors\":\"Aisling Molloy\",\"doi\":\"10.1002/psb.2077\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Monoamine oxidase inhibitors (MAOIs) are generally only initiated by specialists because of safety concerns, making GPs more wary of these medicines. This article discusses the important side‐effects and interactions of MAOIs and how these can be minimised, and explains why MAOI prescribing may be safer than we are led to believe.\",\"PeriodicalId\":88184,\"journal\":{\"name\":\"The Prescriber\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Prescriber\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/psb.2077\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/psb.2077","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

单胺氧化酶抑制剂(MAOIs)通常仅由专家出于安全考虑而启动，这使得全科医生对这些药物更加警惕。本文讨论了MAOIs的重要副作用和相互作用，以及如何将其最小化，并解释了为什么开具MAOIs处方可能比我们所认为的更安全。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

MAOI prescribing: separating misconceptions from reality

Monoamine oxidase inhibitors (MAOIs) are generally only initiated by specialists because of safety concerns, making GPs more wary of these medicines. This article discusses the important side‐effects and interactions of MAOIs and how these can be minimised, and explains why MAOI prescribing may be safer than we are led to believe.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Prescriber

自引率

0.00%

发文量

期刊最新文献

MAOI prescribing: separating misconceptions from reality Understanding liver function tests: part 1 Diagnosis and management of type 2 diabetes in children Is the NHS ready for new Alzheimer's disease treatments? Prescribing Skills Assessment